Literature DB >> 34499968

Outcomes of Ureteroneocystostomy in Patients With Cancer.

Gillian L Stearns1, Amy L Tin2, Nicole E Benfante2, Daniel D Sjoberg2, Jaspreet S Sandhu3.   

Abstract

OBJECTIVE: To determine the durability of ureteroneocystostomy as well as pre- or post-operative factors that may be associated with failure to provide appropriate renal drainage.
METHODS: A total of 290 patients who underwent ureteral reimplantation to native bladder between 2003 and 2015 were identified. After excluding pediatric patients and those without any follow-up, 255 patients, 3 of whom had a subsequent contralateral reimplantation were included, for 258 observations. Kaplan-Meier method and univariate Cox models were used to assess whether factors such as radiation, prior abdominal surgery, age at re-implantation, gender and BMI are associated with re-implantation failure.
RESULTS: Among 258 observations, there were 27 failures. Median follow-up time was 1.1 years from re-implantation surgery among patients without a failure.1 and 5-year ureteral re-implantation failure is 7% (95% CI 4%, 12%) and 22% (95% CI 15%, 33%), respectively. On univariate analysis, post-operative radiation was found to be strongly associated with poorer ureteral re-implantation survival (HR: 6.62; CI 2.40, 18.29; P = .0003) No significant association between re-implantation failure-free survival and age at reimplantation, gender, BMI, previous abdominal surgery, preoperative radiation and adjuvant radiation was noted (all P > .4).
CONCLUSIONS: Ureteroneocystotomy in the malignant setting has reasonable success rates through five years. No preoperative factors were associated with re-implantation failure. While all patients need to be followed due to increasing rates of failure with time, patients receiving palliative or salvage radiation therapy appear to be more prone to failure requiring further intervention.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 34499968      PMCID: PMC9552518          DOI: 10.1016/j.urology.2021.08.032

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.633


  13 in total

1.  Open, laparoscopic, and robotic ureteroneocystotomy for benign and malignant ureteral lesions: a comparison of over 100 minimally invasive cases.

Authors:  Sammy E Elsamra; Nithin Theckumparampil; Bradley Garden; Manaf Alom; Nikhil Waingankar; David A Leavitt; Jessica Kreshover; Michael Schwartz; Louis R Kavoussi; Lee Richstone
Journal:  J Endourol       Date:  2014-12       Impact factor: 2.942

2.  Intraoperative electron beam radiation therapy for recurrent locally advanced rectal or rectosigmoid carcinoma.

Authors:  C G Willett; P C Shellito; J E Tepper; R Eliseo; K Convery; W C Wood
Journal:  Cancer       Date:  1991-03-15       Impact factor: 6.860

3.  Extended pelvic resections for recurrent or persistent uterine and cervical malignancies: an update on out of the box surgery.

Authors:  V Andikyan; F Khoury-Collado; Y Sonoda; S R Gerst; K M Alektiar; J S Sandhu; B H Bochner; R R Barakat; P J Boland; D S Chi
Journal:  Gynecol Oncol       Date:  2012-01-28       Impact factor: 5.482

4.  Preoperative versus postoperative chemoradiotherapy for rectal cancer.

Authors:  Rolf Sauer; Heinz Becker; Werner Hohenberger; Claus Rödel; Christian Wittekind; Rainer Fietkau; Peter Martus; Jörg Tschmelitsch; Eva Hager; Clemens F Hess; Johann-H Karstens; Torsten Liersch; Heinz Schmidberger; Rudolf Raab
Journal:  N Engl J Med       Date:  2004-10-21       Impact factor: 91.245

5.  Complete excision of pelvic viscera for advanced carcinoma; a one-stage abdominoperineal operation with end colostomy and bilateral ureteral implantation into the colon above the colostomy.

Authors:  A BRUNSCHWIG
Journal:  Cancer       Date:  1948-07       Impact factor: 6.860

6.  Ureteral stent insertion for gynecologic interstitial high-dose-rate brachytherapy.

Authors:  D Jeffrey Demanes; Robyn Banerjee; Benjamin L Cahan; Steve P Lee; Sang-June Park; Julia M Fallon; Paula Reyes; Thanh Q Van; Michael L Steinberg; Mitchell R Kamrava
Journal:  Brachytherapy       Date:  2014-12-31       Impact factor: 2.362

Review 7.  Analysis of local recurrence rates after surgery alone for rectal cancer.

Authors:  J L McCall; M R Cox; D A Wattchow
Journal:  Int J Colorectal Dis       Date:  1995       Impact factor: 2.571

Review 8.  Indications, techniques and outcomes for pelvic exenteration in gynecological malignancy.

Authors:  Manpreet Kaur; Steven Joniau; André D'Hoore; Ignace Vergote
Journal:  Curr Opin Oncol       Date:  2014-09       Impact factor: 3.645

9.  Urologic complications of composite resection following combined modality treatment of colorectal cancer.

Authors:  Peter K Stotland; Kouros Moozar; Jonathan A Cardella; Neil E Fleshner; Sharon Sharir; Andrew J Smith; Carol J Swallow
Journal:  Ann Surg Oncol       Date:  2009-08-13       Impact factor: 5.344

10.  Outcomes of distal ureteral reconstruction through reimplantation with psoas hitch, Boari flap, or ureteroneocystostomy for benign or malignant ureteral obstruction or injury.

Authors:  Sven Wenske; Carl A Olsson; Mitchell C Benson
Journal:  Urology       Date:  2013-05-02       Impact factor: 2.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.